Home > Biotech and Pharmaceutical Companies > Georgia Biotech and Pharmaceutical Companies
Address:
3360 Shelby Ln Suite 1010
Atlanta, GA 30344
Phone:
(404) 344-0274
Website:
See Also:
This is a business listing for Dr. Valerie Robbins-Acker, O.D., located in Atlanta, GA. You can find them at 3360 Shelby Ln Suite 1010, Atlanta, GA, 30344, contact them at (404) 344-0274, or visit their website. This listing is provided by colorbasepair.com as part of our Biotech and Pharmaceutical Companies directory, under Georgia Biotech and Pharmaceutical Companies.
What services does Dr. Valerie Robbins-Acker, O.D. offer?
This listing provides contact information for Dr. Valerie Robbins-Acker, O.D.. For details about the specific services they offer, please visit their website or contact them directly.
Where is Dr. Valerie Robbins-Acker, O.D. located?
Dr. Valerie Robbins-Acker, O.D. is located at: 3360 Shelby Ln Suite 1010, Atlanta, GA 30344.
What is the phone number for Dr. Valerie Robbins-Acker, O.D.?
The phone number for Dr. Valerie Robbins-Acker, O.D. is: (404) 344-0274.
What is the website for Dr. Valerie Robbins-Acker, O.D.?
Dr. Valerie Robbins-Acker, O.D.'s website is: https://www.visionworks.com.
How can I contact Dr. Valerie Robbins-Acker, O.D.?
You can contact Dr. Valerie Robbins-Acker, O.D. by phone at (404) 344-0274. You can also visit their website at: https://www.visionworks.com.
I am the owner of this listing. How can I update or remove it?
You can update or remove this listing by clicking the this link: Update/Remove This Listing.
How to add a new listing to Biotech and Pharmaceutical Companies?
You can add a new listing to Biotech and Pharmaceutical Companies by clicking the this link: Add New Listing.
You can find more similar services in Georgia Biotech and Pharmaceutical Companies from our Biotech and Pharmaceutical Companies Directory.
Here are some other listings in the Atlanta, GA Biotech and Pharmaceutical Companies Directory: The Modern Apothecary, Advanced Cardiac Devices, S.S.S. Company, Medical Care Concepts, CLR Capital Group.